About Jeffrey Burton
Jeffrey Burton is a chief financial officer at Halia Therapeutics.
Jeffrey Burton first appears on SEC filings in 2022.
Experience
This experience comes from Jeffrey Burton's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jeffrey Burton in the role, so the role may have started earlier or lasted longer.
Halia Therapeutics, Inc. Current
Chief Financial Officer
2020 – Present · Lehi, UT
Develops investigational drugs for people with inflammatory and neurological diseases.
TI
Tolero Pharmaceuticals, Inc.
Controller
2015 – 2020
SA
SanDisk
Assistant Controller
2011 – 2015
DT
Deloitte & Touche
Audit Senior
2008 – 2011
WM
Wasatch Property Management
Property Manager
2004 – 2006
Key Colleagues at Startups
The people Jeffrey Burton works with at each company, as listed on that company's latest Form D.
Halia Therapeutics, Inc. · Form D, Aug 31, 2026
Preston Campbell
Director
MB
Mary Beckerle
Director
David Checketts
Director
Gary Sabin
Executive Chairman
David Bearss
Chief Executive Officer and director
John Kauwe
Co-Founder and director